ADXN.SW Gross Margin

The Gross Margin of Addex Therapeutics Ltd (ADXN.SW) is -958.33%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

ADXN.SW Gross Margin - Historical Value

Date	Value
2023-12-31	-958.33%

ADXN.SW Gross Margin - Peers Comparison

Ticker	Name	Value
ALONX.PA	Onxeo SA	64.38%
ERYP.PA	Erytech Pharma SA	7775.20%
GNRO.PA	Geneuro SA	7775.20%
ISOFOL.ST	Isofol Medical AB (publ)	-4773.23%
PA8.DE	Paion AG	94.10%
ADCT	ADC Therapeutics SA	91.60%
COX.PA	Nicox SA	100.00%
OPTI.L	OptiBiotix Health PLC	49.69%
BML.WA	Synthaverse SA	55.44%
BONEH.HE	BBS-Bioactive Bone Substitutes Oyj	7775.20%
BSLN.SW	Basilea Pharmaceutica AG Allschwil	81.45%
ECX.DE	Epigenomics AG	75.26%
OKYO.L	OKYO Pharma Ltd	7775.20%
ACIU	AC Immune SA	7775.20%
ASIT.BR	DMS Imaging SA	25.00%
IDIA.SW	Idorsia Ltd	68.07%
ALPHA.PA	Pharnext SA	-14187.50%
VECT	VectivBio Holding AG	7775.20%
OASM.ST	Oasmia Pharmaceutical AB	-6845.60%
OBSV	Obseva SA	7775.20%
VICO.ST	Vicore Pharma Holding AB	197.14%
ACOU.ST	Acousort AB	-84.78%
CIR.L	Circassia Group PLC	68.10%
CRSP	CRISPR Therapeutics AG	7775.20%
DEST.L	Destiny Pharma PLC	7775.20%
DNL.L	Diurnal Group PLC	78.16%
RLF.SW	Relief Therapeutics Holding SA	69.41%
TNG.PA	Transgene SA	-700.96%
B8F.DE	Biofrontera AG	80.64%
BIO.MC	Biosearch SA	39.64%
BIOPOR.CO	Bioporto A/S	67.68%
CYXO.ST	Cyxone AB	100.00%
KAN.ST	Kancera AB	70.00%
MOLN.SW	Molecular Partners AG	99.80%